tadalafil has been researched along with mirabegron in 4 studies
| Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (mirabegron) | Trials (mirabegron) | Recent Studies (post-2010) (mirabegron) |
|---|---|---|---|---|---|
| 1,742 | 392 | 1,089 | 558 | 131 | 538 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Hood, B | 1 |
| de Groat, WC | 1 |
| Fuse, M; Kaga, K; Kageyama, S; Sakata, K; Tokunaga, S; Yamanishi, T; Yokoyama, T | 1 |
| Azis, A; Ciayadi, TA; Hendarto, J; Kholis, K; Palinrungi, MA; Syahrir, S; Syarif, S | 1 |
1 review(s) available for tadalafil and mirabegron
| Article | Year |
|---|---|
Common theme for drugs effective in overactive bladder treatment: inhibition of afferent signaling from the bladder.
Topics: Acetanilides; Afferent Pathways; Animals; Botulinum Toxins, Type A; Carbolines; Humans; Phosphodiesterase 5 Inhibitors; Tadalafil; Thiazoles; Urinary Bladder, Overactive | 2013 |
2 trial(s) available for tadalafil and mirabegron
| Article | Year |
|---|---|
A randomized controlled study of the efficacy of tadalafil monotherapy versus combination of tadalafil and mirabegron for the treatment of persistent overactive bladder symptoms in men presenting with lower urinary tract symptoms (CONTACT Study).
Topics: Acetanilides; Aged; Aged, 80 and over; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Tadalafil; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urological Agents | 2020 |
A randomized controlled trial study on effectiveness between tadalafil versus combination mirabegron and solifenacin on treatment of ureteral stent-related symptoms.
Topics: Humans; Pain; Quality of Life; Solifenacin Succinate; Stents; Tadalafil; Urological Agents | 2023 |
1 other study(ies) available for tadalafil and mirabegron
| Article | Year |
|---|---|
Lower urinary tract dysfunction: From basic science to clinical management. Foreword.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Afferent Pathways; Biomarkers; Botulinum Toxins; Carbolines; Humans; Lower Urinary Tract Symptoms; Phosphodiesterase 5 Inhibitors; Signal Transduction; Tadalafil; Thiazoles; Urinary Bladder, Overactive; Urothelium | 2013 |